MAPT and Alzheimer disease: As shown here, 6-month-old SAMP8 mice exhibited an increased amyloid and tau pathologies, as evaluated by several markers such as sAPPβ, Aβ40, Aβ42, and p-tau, indicating that they already had early molecular and clinical features of AD.